Ambey Laboratories Limited — Board Meeting, 27-06-2025: Outcome of Board Meeting

Ambey Laboratories has announced a board meeting on which it approved proposals to increase its authorised share capital from ₹25 Cr to ₹37 Cr and amend its Articles of Association to allow issuance of warrants and convertible securities. The board also approved a preferential issue of up to 1.08 Cr warrants at ₹46 each, aggregating nearly ₹50 Cr, to promoters and other investors, with 25% upfront payment. Borrowing limits are set to rise from ₹7 Cr to ₹10 Cr. An extraordinary general meeting will be held to seek shareholder approval on these key matters.